MedTrace Logo

Cross-linked and Non-cross-linked Hyaluronic Acid in Subdeltoid Bursitis

NCT06508125 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2024-07-19

No results posted yet for this study

Summary

This study aims to compare the efficacy of different structures of hyaluronic acid, namely cross-linked and non-cross-linked hyaluronic acid, in treating subdeltoid bursitis.

Conditions

  • Subdeltoid Bursitis
  • Hyaluronic Acid

Interventions

DRUG

cross-linked hyaluronic acid

cross-linked hyaluronic acid injection with physical therapy

DRUG

non-cross-linked hyaluronic acid

non-cross-linked hyaluronic acid injection with physical therapy

Sponsors & Collaborators

  • Taipei Medical University

    lead OTHER

Principal Investigators

  • Ru-Lan Hsieh, MD · Shin Kong Wu Ho-Su Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-25
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06508125 on ClinicalTrials.gov